Pricing Log in Create free account
Friday 6 November 2026 Export NVS’s income statement to Excel — free account

Novartis AG

NVS Healthcare Drug Manufacturers General

Novartis AG’s revenue for fiscal 2025 (year ended December 2025) was $56.7 billion, up 9.57% from fiscal 2024.

Revenue
+4.67%
EPS
−69.1%
Free cash flow
−17.8%
Total debt
+53.9%

Quarter to September 2026, against a year earlier

161.13 0.80 −0.49%
Market cap
$296.4B
P/E
30.9×
Fwd P/E
23.2×
Dividend yield
2.93%
F-score
8/9
Altman Z
4.13
Beneish M
−2.49
Dividend safety
66/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Novartis AG (NVS) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Novartis AG (NVS) trades at a EV/EBITDA of 15.6×. Over the past ten years it has ranged from 11.1× (October 2025) to 25.6× (December 2020); the current reading is higher than 46% of that period. That is above the Drug Manufacturers General industry median of 14.8× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.6× 4.21%
FY2024 12.1× (26.71%)
FY2023 16.5× 22.10%
FY2022 13.5× (17.03%)
FY2021 16.3× (6.72%)
FY2020 17.5× (3.92%)
FY2019 18.2× (11.96%)
FY2018 20.7× 1.33%
FY2017 20.4× 60.76%
FY2016 12.7× (17.44%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.9× (7.28%)
Jun 2026 15.0× 2.32%
Mar 2026 14.7× 16.07%
Dec 2025 12.6× 8.38%
43 more quarters

Against its own ten years

Low 11.1× High 25.6×
Ten-year median 15.9×
Current reading's percentile 46

EV/EBITDA against peers

Company EV/EBITDA
NVO Novo Nordisk A/S compare 7.3×
PFE Pfizer Inc. compare 10.9×
AZN AstraZeneca PLC compare 14.8×
NVS Novartis AG 15.6×
AMGN Amgen Inc. compare 17.6×
ABBV AbbVie Inc. compare 20.1×
JNJ Johnson & Johnson compare 24.4×
MRK Merck & Co., Inc. compare 29.7×
GILD Gilead Sciences, Inc. compare 505×
Drug Manufacturers General industry median 14.8×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on NVS